TABLE 2.

Pathological characteristics and long-term followup of 136 patients treated with radical prostatectomy in the MSKCC phase III trial

	RP only (n = 64)	NHT and RP (n = 72)
Organ confined disease,* n (%)	51 (80)	61 (85)
Extracapsular extension, n (%)	13 (20)	10 (14)
Seminal vesicle invasion, n (%)	4 (6)	3 (4)
Lymph node metastasis, n (%)	2 (3)	1 (1)
Positive surgical margin, n (%)	24 (38)	14 (19)
Local recurrence	1	1
Metastases	3	3
Death from prostate cancer	0	1
Death from unknown causes	5	9

^*Defined as the absence of extracapsular extension, seminal vesicle invasion, or lymph node metastasis.

RP, radical prostatectomy; NHT, neoadjuvant hormone therapy